Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3

Status

Completed 10Unknown 7Recruiting 4Active not recruiting 3Terminated 2Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 7INDUSTRY 2

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 1Breast 1

Conditions

Pancreatic Neoplasms 1Lymphedema 1Locally Advanced Rectal Cancer 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Advanced Esophageal Cancer 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Unknown × OTHER × Combined Modality Therapy × Clear all
NCT03034473 2023-12-28

TransValid-A

University Medical Center Goettingen

Phase NA Unknown
200 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT05174156 2022-07-14

Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Unknown
50 enrolled
Gastrointestinal

Advanced Esophageal Cancer

NCT04718701 2021-08-16

ATNPA

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Unknown
53 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04846452 2021-08-12

Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Unknown
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04413734 2020-06-04

Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma

Zhejiang University

Phase 2 Unknown
120 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT03138044 2019-05-14

Combined Ipsilateral Liver Lobe Devascularization and Alcohol Treatment of the Large Hepatocellular Carcinoma

The National Ribat University

Phase NA Unknown
12 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02165696 2014-06-17

LYMPHATIC

University of Malaga

Phase NA Unknown
44 enrolled
Breast

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡